Apocrine Carcinoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Agnostic Therapy in Rare Solid Tumors (NCT06638931) | Instituto do Cancer do Estado de São Paulo | 2024-07-16 |
| Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625) | National Cancer Institute (NCI) | 2017-09-27 |
Track Apocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.